ESMO Breast Cancer 2019: Programme

The ESMO Breast Cancer 2019 programme is online!

Access the online programme


ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. It will be a multidisciplinary meeting with a global scope, involving top scientists and taking place in Europe.

Learing objectives:

  • To advance knowledge
  • To integrate translational research into cancer care
  • To further improve precision medicine
  • To disseminate education and
  • To improve the practice of breast cancer specialists worldwide

The 2019 programme features sessions on innovative treatments, DNA damage, early clinical opportunities, immunotherapy and breast cancer response, metabolism, regulation of breast cancer diversity, and resistance to targeted therapy. These topics span basic, clinical, epidemiologic, prevention, and translational research areas that have implications for treatment now and in the future.


The congress webcasts will include all the sessions of the official programme, where speaker permission is granted, and will be available on this website and on OncologyPRO for ESMO members.


ESMO-MORA: The ESMO Breast 2019 programme will be submitted for ESMO-MORA category 1 points accreditation. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.